Contact this trialFirst, we need to learn more about you.
Topical Treatment
PRN473 (SAR444727) +1 More for Atopic Dermatitis
Recruiting0 awardsPhase 2
Hamilton, Ontario
This trial tests PRN473, a new medication for treating skin lesions in people with mild to moderate eczema. It aims to help those whose current treatments aren't fully effective by reducing inflammation and improving skin healing.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service